Advertisement
Commentary| Volume 40, ISSUE 4, P282-286, August 2016

Sickeningly Sweet: Does Sugar Cause Type 2 Diabetes? Yes

      The metabolic syndrome, of which type 2 diabetes mellitus is a hallmark disease, affects more than 25% of the adult population in the United States (U.S.) (
      • Ford E.S.
      • Giles W.H.
      • Dietz W.H.
      Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey.
      ). Specifically, type 2 diabetes currently exhibits a U.S. prevalence of 9.3%, while prediabetes is currently estimated to be present in up to 40% of adults. It is assumed that the epidemic rise in obesity is the cause of this upswing in the rate of type 2 diabetes. However, there are 4 separate reasons to doubt this thesis.
      • 1)
        Although obesity prevalence and diabetes prevalence correlate, they are not concordant; there are countries in which populations are obese without having diabetes (such as Iceland, Mongolia and Micronesia), and there are countries in which populations have diabetes without being obese (such as India, Pakistan and China, which manifest a 12% diabetes rate). This lack of concordance is further reinforced by looking at years of life lost because of diabetes as opposed to obesity (
        • Sepúlveda J.
        • Murray C.
        The state of global health in 2014.
        ).
      • 2)
        People forget that 20% of morbidly obese individuals are metabolically healthy and have normal life spans (
        • Chan J.M.
        • Rimm E.B.
        • Colditz G.A.
        • et al.
        Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.
        ,
        • McLaughlin T.
        • Abbasi F.
        • Cheal K.
        • et al.
        Use of metabolic markers to identify overweight individuals who are insulin resistant.
        ,
        • Chen D.L.
        • Liess C.
        • Poljak A.
        • et al.
        Phenotypic characterization of insulin-resistant and insulin-sensitive obesity.
        ), while up to 40% of normal-weight adults harbour metabolic perturbations similar to those that occur with obesity, including hypertension, dyslipidemia, nonalcoholic fatty liver disease and cardiovascular disease (
        • Abbasi F.
        • Chu J.W.
        • Lamendola C.
        • et al.
        Discrimination between obesity and insulin resistance in the relationship with adiponectin.
        ,
        • Voulgari C.
        • Tentolouris N.
        • Dilaveris P.
        • et al.
        Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
        ).
      • 3)
        The trend of diabetes in the U.S. between 1988 and 2012 has demonstrated a 25% increase in prevalence in both the obese and the normal-weight populations (
        • Menke A.
        • Casagrande S.
        • Geiss L.
        • Cowie C.C.
        Prevalence of and trends in diabetes among adults in the United States, 1988–2012.
        )
      • 4)
        The aging process does not explain the prevalence of type 2 diabetes; children as young as 1 through 10 years of age now manifest these same biochemical processes (
        • Wiegand S.
        • Maikowski U.
        • Blankenstein O.
        • et al.
        Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity: A problem that is no longer restricted to minority groups.
        ,
        • Biltoft C.A.
        • Muir A.
        The metabolic syndrome in children and adolescents: A clinician's guide.
        ). Thus, although obesity may be a marker for the pathology, it is clearly not the cause because normal-weight people have type 2 diabetes too. So what is the cause, a cause that everyone is exposed to? And how is it that children experience this degree of metabolic dysfunction?
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ford E.S.
        • Giles W.H.
        • Dietz W.H.
        Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey.
        JAMA. 2002; 287: 356-359
        • Basu S.
        • Yoffe P.
        • Hills N.
        • Lustig R.H.
        The relationship of sugar to population-level diabetes prevalence: An econometric analysis of repeated cross-sectional data.
        PLoS ONE. 2013; 8: e57873
        • Sepúlveda J.
        • Murray C.
        The state of global health in 2014.
        Science. 2014; 345: 1275-1278
        • Chan J.M.
        • Rimm E.B.
        • Colditz G.A.
        • et al.
        Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.
        Diabetes Care. 1994; 17: 961-969
        • McLaughlin T.
        • Abbasi F.
        • Cheal K.
        • et al.
        Use of metabolic markers to identify overweight individuals who are insulin resistant.
        Ann Intern Med. 2003; 139: 802-809
        • Chen D.L.
        • Liess C.
        • Poljak A.
        • et al.
        Phenotypic characterization of insulin-resistant and insulin-sensitive obesity.
        J Clin Endocrinol Metab. 2015; 100: 4082-4091
        • Abbasi F.
        • Chu J.W.
        • Lamendola C.
        • et al.
        Discrimination between obesity and insulin resistance in the relationship with adiponectin.
        Diabetes. 2004; 53: 585-590
        • Voulgari C.
        • Tentolouris N.
        • Dilaveris P.
        • et al.
        Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
        J Am Coll Cardiol. 2011; 58: 1343-1350
        • Menke A.
        • Casagrande S.
        • Geiss L.
        • Cowie C.C.
        Prevalence of and trends in diabetes among adults in the United States, 1988–2012.
        JAMA. 2015; 314: 1052-1062
        • Wiegand S.
        • Maikowski U.
        • Blankenstein O.
        • et al.
        Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity: A problem that is no longer restricted to minority groups.
        Eur J Endocrinol. 2004; 151: 199-206
        • Biltoft C.A.
        • Muir A.
        The metabolic syndrome in children and adolescents: A clinician's guide.
        Adolesc Med State Art Rev. 2009; 20: 109-120
        • Lustig R.H.
        Fat chance: Beating the odds against sugar, processed food, obesity, and disease.
        Hudson Street Press, New York, NY2012
        • Yudkin J.
        Pure, white, and deadly.
        Viking, New York1972
        • Lustig R.H.
        Fructose: Metabolic, hedonic, and societal parallels with ethanol.
        J Am Diet Assoc. 2010; 110: 1307-1321
        • Lustig R.H.
        Fructose: It's “alcohol without the buzz”.
        Adv Nutr. 2013; 4: 226-235
        • Nagai Y.
        • Yonemitsu S.
        • Erion D.M.
        • et al.
        The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance.
        Cell Metab. 2009; 9: 252-264
        • Bremer A.A.
        • Mietus-Snyder M.L.
        • Lustig R.H.
        Toward a unifying hypothesis of metabolic syndrome.
        Pediatrics. 2012; 129: 557-570
        • Malik V.S.
        • Popkin B.M.
        • Bray G.A.
        • et al.
        Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk.
        Circulation. 2010; 121: 1356-1364
        • Bray G.A.
        Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people.
        Adv Nutr. 2013; 4: 220-225
        • Ruff J.S.
        • Suchy A.K.
        • Hugentobler S.A.
        • et al.
        Human-relevant levels of added sugar consumption increase female mortality and lower male fitness in mice.
        Nat Commun. 2013; 4: 2245
        • Bremer A.A.
        • Stanhope K.L.
        • Graham J.L.
        • et al.
        Fructose-fed rhesus monkeys: A nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes.
        Clin Transl Sci. 2011; 4: 243-252
        • EPIC-Interact Consortium
        Consumption of sweet beverages and type 2 diabetes incidence in European adults: Results from EPIC-InterAct.
        Diabetologia. 2013; 56: 1520-1530
        • Imamura F.
        • O'Connor L.Y.Z.
        • Mursu J.
        • et al.
        Consumption of sugar-sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: Systematic review, meta-analysis, and estimation of population attributable fraction.
        BMJ. 2015; 351: h3576
        • Barker F.G.
        What is medical evidence?.
        Clin Neurosurg. 2009; 56: 24-33
        • Lustig R.H.
        • Mulligan K.
        • Noworolski S.
        • et al.
        Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome.
        Obesity (Silver Spring). 2016; 24 (Epub Oct 27): 453-460
        • Stanhope K.L.
        • Schwarz J.M.
        • Keim N.L.
        • et al.
        Consuming fructose-, not glucose-sweetened beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.
        J Clin Invest. 2009; 119: 1322-1334
        • Maersk M.
        • Belza A.
        • Stødkilde-Jørgensen H.
        • et al.
        Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: A 6-month randomized intervention study.
        Am J Clin Nutr. 2012; 95: 283-289
        • Newgard C.B.
        • An J.
        • Bain J.R.
        • et al.
        A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.
        Cell Metab. 2009; 9: 311-326
        • Te Morenga L.
        • Mallard S.
        • Mann J.
        Dietary sugars and body weight: Systematic review and meta-analyses of randomised controlled trials and cohort studies.
        BMJ. 2013; 346: e7492
        • Sievenpiper J.L.
        • de Souza R.J.
        • Mirrahimi A.
        • et al.
        Effect of fructose on body weight in controlled feeding trials: Asystematic review and meta-analysis.
        Ann Intern Med. 2012; 156: 291-304
        • Cozma A.I.
        • Sievenpiper J.L.
        • de Souza R.J.
        • et al.
        Effect of fructose on glycemic control in diabetes: A systematic review and meta-analysis of controlled feeding trials.
        Diabetes Care. 2012; 35: 1611-1620
        • Wang D.
        • Sievenpiper J.L.
        • de Souza R.J.
        • et al.
        Effect of fructose on postprandial triglycerides: A systematic review and meta-analysis of controlled feeding trials.
        Atherosclerosis. 2014; 232: 125-133
        • Sievenpiper J.L.
        • Carleton A.J.
        • Chatha S.J.
        • et al.
        Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: Systematic review and meta-analysis of experimental trials in humans.
        Diabetes Care. 2009; 32: 1930-1937
        • Satija A.
        • Yu E.
        • Willett W.C.
        • Hu F.B.
        Understanding nutritional epidemiology and its role in policy.
        Adv Nutr. 2015; 6: 5-18
        • Chiu S.
        • Sievenpiper J.L.
        • de Souza R.J.
        • et al.
        Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of controlled studies.
        Eur J Clin Nutr. 2014; 68: 416-423
        • Rumessen J.J.
        • Gudmand-Hoyer E.
        Absorption capacity of fructose in healthy adults: Comparison with sucrose and its constituent monosaccharides.
        Gut. 1986; 27: 1161-1168
        • Hudgins L.C.
        • Parker T.S.
        • Levine D.M.
        • Hellerstein M.K.
        A dual sugar challenge test for lipogenic sensitivity to dietary fructose.
        J Clin Endocrinol Metab. 2011; 96: 861-868
        • Lesser L.I.
        • Ebbeling C.B.
        • Goozner M.
        • et al.
        Relationship between funding source and conclusion among nutrition-related scientific articles.
        PLoS Med. 2007; 4: e5
        • Bes-Rastrollo M.
        • Schulze M.B.
        • Ruiz-Canela M.
        • Martinez-Gonzalez M.A.
        Financial conflicts of interest and reporting bias regarding the association between sugar-sweetened beverages and weight gain: A systematic review of systematic reviews.
        PLoS Med. 2013; 10: e1001578
        • Lustig R.H.
        • Schmidt L.A.
        • Brindis C.D.
        The toxic truth about sugar.
        Nature. 2012; 487: 27-29
        • Sugar Coated
        Movie Documentary, Michele Hozer, director, Janice Dawe, producer.
        Cutting Factory. 2015